Arkema Divests Phosphorus Derivatives Business
Arkema has announced the proposed divestment of Febex, a company specializing in phosphorus-based chemistry, to Belgian group Prayon.
Arkema has proposed the divestment of Febex, a global player in phosphorus derivatives (high purity phosphoric acid, sodium hypophosphite and derivatives), used primarily in electronics and in the pharmaceuticals industry. Part of the Performance Additives Business Line and with little integration within the Group’s other activities, Febex reported sales of around €30 million in 2021, employs 59 people, and operates 1 site in Switzerland.
Febex will join Prayon, an Belgian industrial group specializing in phosphorus-based chemistry.
The divestment is expected to be finalized in 1st quarter 2023, and is subject to information and prior consultation process with employee representative bodies in France and to approval by the relevant Swiss authorities.
Related Content
-
An Altruistic Growth Strategy Puts People First
Professional Plating emphasizes investing in its team and fostering a supportive environment on the shop floor.
-
Altana Announces New Leadership
Prof. Dr. Frank Richter named new chairman of Altana’s supervisory board.
-
VCS Hybrid Cup System Helps Increase Productivity
The system combines the benefits of vented hard cups and sealed liners.
